Literature DB >> 7018483

The antibody response to Brucella: immunoglobulin response measured by enzyme-linked immunosorbent assay and conventional tests.

G L Gilbert, L A Hawes.   

Abstract

An enzyme-linked immunosorbent assay was adapted to measure total and individual classes of brucella antibody. The results were compared with those of conventional tests for brucella antibody on the sera of a number of healthy seropositive abattoir workers and several patients with either acute or suspected chronic brucellosis. IgG was the class of brucella specific immunoglobulin most commonly detected in all groups. IgM was present in the sera of 40% of seropositive abattoir workers, all but one of the patients with recent acute brucellosis or seroconversion and none of those with suspected chronic brucellosis. Many of the abattoir workers' sera which contained brucella specific IgM gave negative results in the direct agglutination test. The presence of brucella specific IgM in the sera of these men was, in most cases, associated with no past history of acute brucellosis and a relatively short period of employment in the abattoir. It is suggested that the presence of brucella specific IgM in the serum of a person occupationally exposed to B. abortus, probably indicates a relatively recent primary infection, either symptomatic or subclinical and has no prognostic significance. Repeated or prolonged exposure is associated with IgG brucella antibodies, often in high titre, irrespective of symptoms. It was not possible, on the basis of any serological tests performed in this study to distinguish healthy people exposed to brucella from those with symptoms consistent with chronic brucellosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018483     DOI: 10.1111/j.1445-5994.1981.tb03734.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  9 in total

1.  Enzyme-linked immunosorbent assay with major outer membrane proteins of Brucella melitensis to measure immune response to Brucella species.

Authors:  S B Hunter; W F Bibb; C N Shih; A F Kaufmann; J R Mitchell; R M McKinney
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM, and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis.

Authors:  G F Araj; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

3.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

4.  Specificity of ELISA anti-immunoglobulin G conjugate in the diagnosis of human brucellosis.

Authors:  A Foz; T Pellicer; J Comerma; J Ariza
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings.

Authors:  G F Araj; A R Lulu; M Y Mustafa; M I Khateeb
Journal:  J Hyg (Lond)       Date:  1986-12

6.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Enzyme-linked immunosorbent assay for diagnosis of brucellosis.

Authors:  J V Saz; M Beltrán; A Díaz; A Agulla; F J Merino; P A Villasante; A C Velasco
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

8.  Demonstration of antibodies against Brucella melitensis 16M lipopolysaccharide and native hapten in human sera by enzyme-linked immunosorbent assay.

Authors:  L Fernandex-Lago; R Diaz
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

9.  False positive seroreactivity to brucellosis in tuberculosis patients: a prevalence study.

Authors:  Mojtaba Varshochi; Jafar Majidi; Marjan Amini; Kamyar Ghabili; Mohammadali M Shoja
Journal:  Int J Gen Med       Date:  2011-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.